Interaksi Lopinavir dan ritonavir dan Trazodon

Lopinavir dan ritonavir dan Trazodon: kedua label peresepan menandai kombinasi ini dengan bahasa yang paling tegas, seperti kontraindikasi, peringatan kotak hitam, atau instruksi untuk menghindarinya.

Mayor

Jangan dikombinasikan tanpa arahan dokter yang meresepkan. Bahasa label di bawah ini adalah yang paling tegas yang digunakan FDA.

Apa kata label FDA

Dari label Trazodon (RALDESY TM) · berlaku sejak 2026-09-01

Mayor

The use of RALDESY Should be avoided in patients with known QT prolongation or in combination with other drugs that are inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, voriconazole), or known to prolong QT interval including Class 1A antiarrhythmics (e.g., quinidine, procainamide) or Class 3 antiarrhythmics (e.g., amiodarone, sotalol), certain antipsychotic…

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Moderat

CYP3A4 Inhibitors: Consider RALDESY dose reduction based on tolerability ( 2.5 , 7 ).

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Moderat

CYP3A4 Inducers: Increase in RALDESY dosage may be necessary ( 2.5 , 7 ).

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Moderat

Strong CYP3A4 Inhibitors Clinical Impact: The concomitant use of RALDESY and strong CYP3A4 inhibitors increased the exposure of trazodone compared to the use of RALDESY alone.

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Moderat

Intervention: If RALDESY is used with a potent CYP3A4 inhibitor, the risk of adverse reactions, including cardiac arrhythmias, may be increased and a lower dose of RALDESY should be considered [see Dosage and Administration (2.5) , Warnings and Precautions (5.3) ].

Interaksi obatberdasarkan golongan obatLihat label di DailyMed

Dari label Lopinavir dan ritonavir (Kaletra) · berlaku sejak 2026-07-23

Mayor

…Non-opioid Analgesic (selective blocker of Nav1.8 sodium channels): suzetrigine PDE5 Inhibitor: sildenafil (Revatio ® ) when used for the treatment of pulmonary arterial hypertension Sedative/Hypnotics: triazolam, orally administered midazolam KALETRA is contraindicated with drugs that are potent CYP3A inducers where significantly reduced lopinavir plasma concentrations…

Kontraindikasiberdasarkan golongan obatLihat label di DailyMed
Mayor

Avoid use in patients with congenital long QT syndrome, those with hypokalemia, and with other drugs that prolong the QT interval.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Mayor

Postmarketing life-threatening cases of cardiac toxicity (including complete AV block, bradycardia, and cardiomyopathy), lactic acidosis, acute renal failure, CNS depression and respiratory complications leading to death have been reported, predominantly in preterm neonates receiving KALETRA oral solution.

Peringatan dan perhatianberdasarkan golongan obatLihat label di DailyMed
Mayor

Sedative/Hypnotics: triazolam, orally administered midazolam ↑ triazolam ↑ midazolam Contraindicated due to potential for prolonged or increased sedation or respiratory depression [see Contraindications ( 4 )] .

Interaksi obatberdasarkan golongan obatLihat label di DailyMed
Moderat

A lower dose of trazodone should be considered.

Interaksi obatmenyebut TrazodonLihat label di DailyMed

Menggunakan lebih dari dua obat ini? Interaksi saling bertumpuk. Periksa seluruh daftar Anda sekaligus; daftar itu tetap berada di peramban Anda.

Buka di pemeriksa

Bukan nasihat medis. Interaction Checker mengutip teks label FDA dan lembar fakta NIH. Penting atau tidaknya suatu interaksi bagi Anda bergantung pada dosis, waktu penggunaan, fungsi ginjal dan hati, serta kondisi lain. Pastikan dengan apoteker atau dokter yang meresepkan.